TABLE 3: Current vs previous

No. of Cases (current year) and percentage change vs. previous year (persons)
Statistically significant difference in 2018 compared to 2015-2017
No statistical significant difference in 2018 compared to 2015-2017
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 384,639 (4.1%) 3.8% 320395 (4.1%) 34172 (4.6%) 9897 (2.3%) 20175 (4.1%)
All xnmsc 0-24 3,607 (-8%) -5.8% 3068 (-7.9%) 273 (-12%) 124 (12.4%) 142 (-15.8%)
All xnmsc 25-59 89,641 (4.3%) 3.1% 75119 (4.5%) 7912 (4.2%) 2530 (3.5%) 4080 (0.2%)
All xnmsc 60-79 208,347 (5.5%) 5.1% 172604 (5.5%) 19013 (6.6%) 5262 (2.5%) 11468 (5.6%)
All xnmsc 80+ 83,044 (0.8%) 1.4% 69604 (0.7%) 6974 (0.4%) 1981 (-0.1%) 4485 (4.7%)
All registrations 625,525 (2.6%) 3.3% 517814 (2.4%) 55489 (2.8%) 18236 (3%) 33986 (5.1%)
Haematology 32,014 (-3.5%) -3.7% 27195 (-3.5%) 2512 (-1.9%) 842 (-1.3%) 1465 (-8%)
Head and Neck 12,659 (3.2%) 4.9% 10210 (2.8%) 1330 (4%) 375 (9.9%) 744 (2.9%)
Lower GI 46,962 (2.7%) 3.5% 38789 (2.2%) 4390 (7.9%) 1282 (2.8%) 2501 (1%)
Upper GI 15,733 (-0.7%) -1.1% 12925 (-0.5%) 1484 (-3.8%) 403 (-5.3%) 921 (5.1%)
HPB 19,356 (2.7%) 2.8% 16123 (2.9%) 1654 (-2.9%) 510 (2.2%) 1069 (9.2%)
Trachea, Bronchus & Lung 48,535 (0.8%) 0.2% 39290 (0.7%) 5400 (2.1%) 1288 (-3.9%) 2557 (2.1%)
Melanoma of skin 17,558 (8.2%) 7.7% 14824 (8.4%) 1414 (6.3%) 423 (9.8%) 897 (6.5%)
Breast 57,408 (3.9%) 3.2% 48030 (3.9%) 5057 (6.8%) 1532 (3.6%) 2789 (-1.5%)
Cervix 3,271 (3.5%) 6.7% 2668 (3.3%) 347 (3.8%) 94 (21.6%) 162 (-1.6%)
Other Female Genitals 19,291 (3.3%) 4.8% 15978 (3.1%) 1685 (1.5%) 549 (6.2%) 1079 (8.4%)
Prostate 58,500 (19.5%) 16.7% 49810 (19.8%) 4222 (21.5%) 1265 (8.1%) 3203 (17.3%)
Kidney 13,039 (0%) -2.1% 10848 (-0.1%) 1230 (4.4%) 310 (-18.6%) 651 (6%)
Bladder 10,294 (0%) 0.6% 8671 (0.1%) 817 (-5.3%) 226 (-1.2%) 580 (9%)
Brain and CNS 5,590 (-2.4%) 3.3% 4667 (-3.7%) 471 (5.4%) 159 (11.4%) 293 (0%)
Thyroid & other endocrine glands 4,381 (8.6%) 11.5% 3723 (7.9%) 371 (12.7%) 129 (11.8%) 158 (13.7%)
CUP 8,420 (-3.1%) 3.8% 6856 (-4.2%) 787 (-3.9%) 215 (17.5%) 562 (5.8%)
Other invasive cancer 11,628 (0.9%) -0.9% 9788 (1.7%) 1001 (-5.6%) 295 (1.8%) 544 (-1.5%)
Breast in situ 8,593 (6.1%) 3.3% 7437 (7.3%) 466 (-5.7%) 303 (20.1%) 387 (-8.7%)
Cervix in situ 24,350 (-12.1%) -15.6% 20300 (-11%) 2038 (-17%) 959 (-12.2%) 1053 (-22%)
Other tumours 52,299 (1.9%) -3.0% 40680 (4.1%) 6327 (-4.4%) 2935 (2.1%) 2357 (-13.7%)
Other non-melanoma skin cancer 1919 (-1.2%) 14.3% 1558 (0.5%) 175 (2.9%) 117 (112.7%) 69 (-58.9%)
Basal cell carcinoma 115008 (0%) 7.8% 96134 (-1.9%) 8586 (4%) 2850 (5.7%) 7438 (23.4%)
Squamous cell carcinoma 38717 (7.5%) 10.2% 31310 (6.6%) 3725 (11.8%) 1175 (10.9%) 2507 (11.5%)